Swiss National Bank’s Arbutus Biopharma ABUS Stock Holding History

Swiss National Bank’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Buy	286,500 +3,100	+1%	+$13.6K	﹤0.01%	2103
2026 Q1	$1.28M	Hold	283,400	–	–	﹤0.01%	2063
2025 Q4	$1.36M	Buy	283,400 +7,100	+3%	+$31.9K	﹤0.01%	2040
2025 Q3	$1.25M	Hold	276,300	–	–	﹤0.01%	2067
2025 Q2	$854K	Hold	276,300	–	–	﹤0.01%	2200
2025 Q1	$964K	Hold	276,300	–	–	﹤0.01%	2146
2024 Q4	$904K	Hold	276,300	–	–	﹤0.01%	2248
2024 Q3	$1.06M	Buy	+276,300	New	+$1.06M	﹤0.01%	2188
2015 Q1	–	Sell	-16,900	Closed	-$259K	–	2547
2014 Q4	$259K	Buy	+16,900	New	+$292K	﹤0.01%	2444

Other funds holding ABUS

TSC

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Swiss National Bank's ABUS Position: Q2 2026 in Review

Swiss National Bank increased its Arbutus Biopharma (ABUS) stake by 1.1% in Q2 2026, buying an estimated $13.6K and bringing the position to 286,500 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2103.

Swiss National Bank first reported a position in ABUS in Q4 2014 and has held it in 9 quarters since. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

Swiss National Bank held 286,500 shares of Arbutus Biopharma worth $1.38M as of Q2 2026.
Swiss National Bank bought 3,100 Arbutus Biopharma shares in Q2 2026, an estimated $13.6K.
Arbutus Biopharma made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2103 holding.
Swiss National Bank first reported a position in Arbutus Biopharma in Q4 2014 and has held it in 9 quarters since.
176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.